Robert C. Bast, Jr., MD, vice president, Translational Research, The University of Texas MD Anderson Cancer Center, discusses a study that could help in early detection of ovarian cancer before CA-125 rises in patients.
Robert C. Bast, Jr., MD
Advertisement
Articles by Robert C. Bast, Jr., MD
Dr. Robert Bast, from the MD Anderson Cancer Center, Discusses New Biomarker Panels for Ovarian Cancer Screening.
Advertisement
Latest Updated Articles
Dr. Bast Discusses Biomarkers for Ovarian CancerJuly 19th 2012
Dr. Bast on Earlier Detection of Ovarian CancerApril 22nd 2015
Advertisement
Advertisement
Trending on OncLive
1
Managing Long-Term Toxicities and Emerging Therapies in ALK-Positive NSCLC
2
Five Under 5: Top Oncology Videos for the Week of 6/28
3
The OncFive: Top Oncology Articles for the Week of 6/28
4
Rusfertide Maintains Long-Term Thromboembolism Control in Phlebotomy-Dependent Polycythemia Vera
5